Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 4/20 | 0.48 |
| ▸ | GAA | P10253 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.48 |
| ▸ | GFER | P55789 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | TOP2A | P11388 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.46 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.45 |
| ▸ | PAX8 | Q06710 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 4/20 | 0.44 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL167454 | 1.00 | KDM4E (0.59) | KDM4EALDH1A1RAB9AGAASMN1; SMN2 | |
| SCHEMBL29472019 | 1.00 | KDM4E (0.59) | KDM4EALDH1A1RAB9AGAASMN1; SMN2 | |
| SCHEMBL6917834 | 0.84 | KDM4E (0.58) | KDM4EALDH1A1RAB9AGAASMN1; SMN2 | |
| SCHEMBL5589082 | 0.84 | KDM4E (0.58) | KDM4EALDH1A1RAB9AGAASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL1539025 | 0.84 | SIGMAR1 (0.44) | KDM4EALDH1A1RAB9AGAASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL3290040 | 0.84 | SIGMAR1 (0.44) | KDM4EALDH1A1RAB9AGAASMN1; SMN2 | |
| SCHEMBL2229008 | 0.84 | SIGMAR1 (0.46) | KDM4EALDH1A1RAB9AGAASMN1; SMN2 | |
| SCHEMBL808900 | 0.84 | SIGMAR1 (0.46) | KDM4EALDH1A1RAB9AGAASMN1; SMN2 | |
| SCHEMBL19278159 | 0.83 | KDM4E (0.41) | KDM4EALDH1A1RAB9AGAASMN1; SMN2 | |
| SCHEMBL16101289 | 0.83 | KDM4E (0.49) | KDM4EALDH1A1RAB9AGAASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1363923-B1 | RHODIUM AND IRIDIUM COMPLEXES | MERCK PATENT GMBH (DE) | 2009-04-01 | — | — | EP | claimed |
| US-12635401-B2 | Metal complexes | UDC Ireland (IE) | 2026-05-19 | — | — | US | disclosed |
| US-20260070936-A1 | METAL COMPLEXES | UDC IRELAND LTD (IE) | 2026-03-12 | — | — | US | disclosed |
| EP-4069709-B1 | METAL COMPLEXES | UDC IRELAND LTD (IE) | 2025-04-23 | — | — | EP | disclosed |
| US-12250871-B2 | Metal complexes | UDC IRELAND LIMITED (IE) | 2025-03-11 | — | — | US | disclosed |
| US-20240260448-A1 | Metal Complexes | UDC IRELAND LIMITED (IE) | 2024-08-01 | — | — | US | disclosed |
| US-11917901-B2 | Metal complexes | UDC IRELAND LIMITED (IE) | 2024-02-27 | — | — | US | disclosed |
| US-11746167-B2 | Process for the preparation of polyisoprene with a mainly alternating cis-1,4- alt-3,4 structure in the presence of a catalytic system comprising a pyridyl iron complex | VERSALIS S.P.A. (IT) | 2023-09-05 | — | — | US | disclosed |
| US-11746167-B2 | Process for the preparation of polyisoprene with a mainly alternating cis-1,4- alt-3,4 structure in the presence of a catalytic system comprising a pyridyl iron complex | VERSALIS S.P.A. (IT) | 2023-09-05 | — | — | US | disclosed |
| US-20230056324-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2023-02-23 | — | — | US | disclosed |
| EP-2297276-A1 | COMPLEXES FOR USE IN OPTOELECTRONIC COMPONENTS | Merck Patent GmbH (DE) | 2011-03-23 | — | — | EP | disclosed |
| EP-2297275-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | Merck Patent GmbH (DE) | 2011-03-23 | — | — | EP | disclosed |
| US-7816531-B2 | Metal complexes | MERCK PATENT GMBH (DE) | 2010-10-19 | — | — | US | disclosed |
| WO-2010099852-A1 | METAL COMPLEXES HAVING AZABOROL LIGANDS AND ELECTRONIC DEVICE HAVING THE SAME | MERCK PATENT GMBH (DE) | 2010-09-10 | — | — | WO | disclosed |
| WO-2010086089-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2010-08-05 | — | — | WO | disclosed |
| US-20100176386-A1 | LUMINESCENT METAL COMPLEXES FOR ORGANIC ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2010-07-15 | — | — | US | disclosed |
| WO-2010015307-A1 | ELECTRONIC DEVICES COMPRISING METAL COMPLEXES HAVING ISONITRILE LIGANDS | MERCK PATENT GMBH (DE) | 2010-02-11 | — | — | WO | disclosed |
| WO-2010006681-A1 | COMPLEXES FOR USE IN OPTOELECTRONIC COMPONENTS | MERCK PATENT GMBH (DE) | 2010-01-21 | — | — | WO | disclosed |
| WO-2010006666-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2010-01-21 | — | — | WO | disclosed |
| US-20080027220-A1 | Metal Complexes | MERCK PATENT GMBH (DE) | 2008-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260070936-A1 | METAL COMPLEXES | SCO2, CBR1, CORO1C | KDM4E 4498/4885ALDH1A1 2087/4885RAB9A 2219/4885 |
| US-12635401-B2 | Metal complexes | SCO2, SOD1, NR4A1 | KDM4E 3445/4885ALDH1A1 2069/4885RAB9A 2670/4885 |
| US-20100176386-A1 | LUMINESCENT METAL COMPLEXES FOR ORGANIC ELECTRONIC DEVICES | OCIAD2, OCIAD1, OSTC | KDM4E 4222/4885ALDH1A1 1304/4885RAB9A 2982/4885 |
| US-12250871-B2 | Metal complexes | AP1M1, SOD1, AP3M1 | KDM4E 3628/4885ALDH1A1 3790/4885RAB9A 2076/4885 |
| US-20230056324-A1 | METAL COMPLEXES | MCU, IMMT, SOD1 | KDM4E 4474/4885ALDH1A1 1713/4885RAB9A 1986/4885 |
| US-20080027220-A1 | Metal Complexes | AP1M1, SOD1, AP1G1 | KDM4E 3323/4885ALDH1A1 363/4885RAB9A 1324/4885 |
| US-11746167-B2 | Process for the preparation of polyisoprene with a mainly alternating cis-1,4- alt-3,4 structure in the presence of a catalytic system comprising a pyridyl iron complex | AOC3, AOC2, C5 | KDM4E 4169/4885ALDH1A1 2178/4885RAB9A 771/4885 |
| US-11917901-B2 | Metal complexes | MCOLN2, MCOLN1, AP1M1 | KDM4E 4260/4885ALDH1A1 1631/4885RAB9A 2962/4885 |
| US-20240260448-A1 | Metal Complexes | SOD1, AP1M1, AP3M1 | KDM4E 3816/4885ALDH1A1 3721/4885RAB9A 2201/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.